FibroBox: a novel noninvasive tool for predicting significant liver fibrosis and cirrhosis in HBV infected patients

BACKGROUND: China is a highly endemic area of chronic hepatitis B (CHB). The accuracy of existed noninvasive biomarkers including TE, APRI and FIB-4 for staging fibrosis is not high enough in Chinese cohort. METHODS: Using liver biopsy as a gold standard, a novel noninvasive indicator was developed...

Descripción completa

Detalles Bibliográficos
Autores principales: Lu, Xiao-Jie, Yang, Xiao-Jun, Sun, Jing-Yu, Zhang, Xin, Yuan, Zhao-Xin, Li, Xiu-Hui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7520974/
https://www.ncbi.nlm.nih.gov/pubmed/33005419
http://dx.doi.org/10.1186/s40364-020-00215-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7520974/
https://www.ncbi.nlm.nih.gov/pubmed/33005419
http://dx.doi.org/10.1186/s40364-020-00215-2

Ejemplares similares